Microsoft Discovery, which Microsoft announced at Build 2025, is a new platform that taps agentic AI to 'transform the ...

Israeli artificial intelligence biotech startup SpotitEarly Ltd. today officially launched in the U.S. and announced that it has raised $20.3 million in new funding to scale up its U.S. presence ...

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla ... to formally announce the launch of the Phenesafe AI platform, an AI technology stack specifically ...

The development of Phenesafe AI will help us do all of these elements more quickly, and effectively.” PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) is a biotechnology company focused on the ...

Artificial intelligence is changing the skills needed to succeed. A digitally-literate workforce is absolutely critical.

PharmAla Biotech.“All the while, you must continue to keep focus on your goals: indication, safety profile, and intended function. The development of Phenesafe AI will help us do all of these ...

HONG KONG, May 15, 2025 /PRNewswire/ -- Artificial intelligence has rapidly evolved ... atomic-level 3D interaction predictions. Viva Biotech's approach to drug discovery is grounded in the ...

SOUTH SAN FRANCISCO, Calif.—The race to build useful artificial-intelligence agents that can perform complex actions for people is moving on to a new set of challenges. The large language ...

On May 13, 2025, Viva Biotech successfully held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the advanced and comprehensive AI-Driven Drug Discovery (AIDD) platform to ...

OpenAI unveiled a research preview of a new software engineering agent on Friday, pushing forward in one of the most in-demand areas for artificial intelligence tools. The agent, known as Codex ...

MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is thrilled to formally announce the launch ...